Related references
Note: Only part of the references are listed.
Meeting Abstract
Oncology
Neoadjuvant treatment of HER2 overexpressing primary breast cancer with trastuzumab given concomitantly to epirubicin/cyclophosphamide followed by docetaxel +/- capecitabine. First analysis of efficacy and safety of the GBG/AGO multicenter intergroup-study GeparQuattro
M. Untch et al.
EJC SUPPLEMENTS (2008)
Share Paper
